Showing 1 - 2 results of 2 for search 'Arnon P. Kater', query time: 0.01s Refine Results
  1. 1
    Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients

    Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients by Paul J. Hengeveld, Joyce Schilperoord-Vermeulen, P. Martijn Kolijn, Julie M. N. Dubois, Peter E. Westerweel, Sabina Kersting, Arnon P. Kater, Mark-David Levin, Anton W. Langerak

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL

    Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL by Lavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast, Johanne U. Hermansen, Norman Mack, Sibylle Ohl, Verena Kalter, Murat Iskar, Mathias Kalxdorf, Dennis Friedel, Mandy Rettel, Yashna Paul, Ingo Ringshausen, Eric Eldering, Julie Dubois, Arnon P. Kater, Marc Zapatka, Philipp M. Roessner, Eugen Tausch, Stephan Stilgenbauer, Sascha Dietrich, Mikhail M. Savitski, Sigrid S. Skånland, Jeroen Krijgsveld, Peter Lichter, Martina Seiffert

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: